Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats

Guangwei Yang,Zitian Liu,Shuohui Dong,Xiang Zhao,Zheng Ge,Zhiqiang Cheng,Xiang Zhang,Kexin Wang
DOI: https://doi.org/10.1111/1753-0407.13516
IF: 4.53
2023-12-14
Journal of Diabetes
Abstract:Highlights The efficacy of duodenal‐jejunal bypass (DJB) in ameliorating diabetic cardiomyopathy has been documented; however, the precise mechanism by which it mitigates cardiac oxidative stress, which plays an important role in diabetic cardiomyopathy, remains elusive. The present investigation revealed that DJB attenuated oxidative stress in diabetic cardiomyopathy rats by activating the adenosine monophosphate (AMP)‐activated protein kinase (AMPK) pathway, thereby augmenting the antioxidative system and elevating the phosphorylation level of nitric oxide synthase (eNOS). The activation of the AMPK pathway by an AMPK agonist in H9C2 cells cultured by glycolipid toxic environment resulted in an elevation of eNOS phosphorylation level and enhancement of the antioxidative system, consequently ameliorating oxidative stress. The application of sera obtained from distinct groups to stimulate H9C2 cells revealed that DJB intervention partially alleviated heart oxidative stress by activating the AMPK pathway, rather than solely by improving blood glucose levels. Background Diabetic cardiomyopathy is a serious complication of obesity with type 2 diabetes and is a major cause of mortality. Metabolic surgery, such as duodenal‐jejunal bypass (DJB), can effectively improve diabetic cardiomyopathy; however, the underlying mechanisms remain elusive. Oxidative stress is one of the pivotal mechanisms of diabetic cardiomyopathy. Our objective was to investigate the effect and potential mechanisms of DJB on oxidative stress in the heart of diabetic cardiomyopathy rats. Methods High‐fat diet combined with intraperitoneal injection of streptozotocin was used to establish diabetic cardiomyopathy rats. DJB was performed on diabetic cardiomyopathy rats, and high glucose and palmitate were used to simulate diabetic cardiomyopathy in H9C2 cells in vitro. Sera from different groups of rats were used for experiments in vivo and in vitro. Results DJB effectively improved oxidative stress and activated the adenosine monophosphate (AMP)‐activated protein kinase (AMPK) pathway to increase endothelial nitric oxide synthase (eNOS) phosphorylation level and the expression of antioxidative system‐related proteins and genes in the heart of diabetic cardiomyopathy rats. AMPK agonists and serum from DJB rats activated the AMPK pathway to increase eNOS phosphorylation level and the expression of antioxidative system‐related proteins and genes and decreased the content of reactive oxygen species in H9C2 cells, but this improvement was almost eliminated by the addition of AMPK inhibitors. Conclusions DJB activates eNOS and enhances the antioxidant system by activating the AMPK pathway—and not solely by improving blood glucose—to improve oxidative stress in the heart of diabetic cardiomyopathy rats.
endocrinology & metabolism
What problem does this paper attempt to address?